Correction: Who still needs multiple access sites in the era of ECIRS and US-guided supine PCNL?
World Journal of Urology · 12.03.2026 · 44 (1)
DOI: 10.1007/s00345-026-06305-4 ↗Kurz gefasst
Korrektur in der Zeitschrift World Journal of Urology, online erschienen am 12.03.2026. Verfasst von Ziv Savin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Icahn School of Medicine at Mount Sinai, 424 W. 59th Street, Suite 4F, New York, NY, 10019, USA. zivsavin23@gmail.com.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Urology, Icahn School of Medicine at Mount Sinai, 424 W. 59th Street, Suite 4F, New York, NY, 10019, USA. zivsavin23@gmail.com.
- Icahn School of Medicine at Mount Sinai, New York, NY, USA.
- Department of Urology, Icahn School of Medicine at Mount Sinai, 424 W. 59th Street, Suite 4F, New York, NY, 10019, USA.
Zitieren
APA
Savin, Z., Geffner, A. D., Frangopoulos, E., Durbhakula, V., Rahmani, L. D., Mandel, A., Dibello, A., Kim, E., Hamlani, A., Gallante, B., Gupta, K., Atallah, W. M., & Gupta, M. (2026). Correction: Who still needs multiple access sites in the era of ECIRS and US-guided supine PCNL?. World Journal of Urology, 44(1). https://doi.org/10.1007/s00345-026-06305-4
Vancouver
Savin Z, Geffner AD, Frangopoulos E, Durbhakula V, Rahmani LD, Mandel A, et al. Correction: Who still needs multiple access sites in the era of ECIRS and US-guided supine PCNL?. World Journal of Urology. 2026;44(1). doi:10.1007/s00345-026-06305-4
BibTeX
@article{Savin2026,
author = {Savin, Ziv and Geffner, Adam Daniel and Frangopoulos, Eve and Durbhakula, Vinay and Rahmani, Linda Dayan and Mandel, Asher and Dibello, Aubrey and Kim, Esther and Hamlani, Ali and Gallante, Blair and Gupta, Kavita and Atallah, William M and Gupta, Mantu},
title = {Correction: Who still needs multiple access sites in the era of ECIRS and US-guided supine PCNL?},
journal = {World Journal of Urology},
year = {2026},
volume = {44},
number = {1},
doi = {10.1007/s00345-026-06305-4}
}
EUVIMED